Propecia vs Avodart: Which DHT Blocker Is Best for Hair Loss in 2025?

Both Propecia (finasteride) and Avodart (dutasteride) lower DHT, a hormone that shrinks hair follicles over time. Finasteride is FDA-approved for hair loss and blocks about 70% of scalp DHT. Dutasteride blocks closer to 90% and may regrow more hair, but it is off-label in the U.S.

Drug	Scalp DHT Drop	FDA Approved?	Daily Dose	Cost	Best For
Finasteride	~70%	Yes	1 mg	$10–20/month	Early or mild loss, first-line treatment
Dutasteride	~90%	No	0.5 mg	$20–40/month	More aggressive loss or poor response to finasteride

Propecia vs Avodart: Key Takeaways

• Finasteride (Propecia) and dutasteride (Avodart) both block DHT, the hormone responsible for miniaturizing hair follicles.
• Finasteride reduces scalp DHT by ~70% and is FDA-approved for hair loss; dutasteride reduces it by ~90% and is more potent but off-label in the U.S.
• Both medications are generally well-tolerated, but some users experience sexual or mood side effects.
• Treatment choice depends on age, family history, response to other therapies, and tolerance of risk.

If you’re comparing options after hearing about DHT blockers online, or you’ve already tried minoxidil, this article breaks down the real differences between Propecia and Avodart based on the latest research and expert consensus.

How These Drugs Work in Hair Follicles

Androgenetic alopecia is driven by DHT (dihydrotestosterone), a hormone made when testosterone is converted by an enzyme called 5-alpha reductase. DHT miniaturizes hair follicles, causing them to shrink and produce thinner, shorter hairs until they eventually stop growing.

Finasteride and dutasteride are 5-alpha reductase inhibitors that reduce this DHT-driven miniaturization.

But which drug is more effective?

Finasteride ≈ 70% scalp DHT drop

Finasteride blocks type II 5-alpha reductase, the version mainly found in hair follicles. Taking 1 mg daily reduces scalp DHT by about 60–70%. That’s enough to slow or halt loss in most men with early to moderate thinning.

Dutasteride ≈ 90% scalp DHT drop

Dutasteride blocks both type I and type II enzymes. Type I is found in the skin and sebaceous glands, while type II targets the follicle. That dual action drops DHT levels by 90% or more.

Efficacy for Hair Regrowth

Recent clinical data suggests that while both finasteride and dutasteride promote hair regrowth, dutasteride may offer superior results.

• In a 2014 randomized trial involving 917 men, dutasteride 0.5 mg led to a greater increase in hair count and shaft thickness within a 2.54 cm target area compared to both finasteride and placebo. Frontal scalp photographs taken over a 24-week period also showed more noticeable improvement with dutasteride. These effects were dose-dependent, reinforcing the drug’s potency as a dual 5-alpha reductase inhibitor.
• More recently, a 2025 network meta-analysis (Gupta et al., JAMA Dermatol) comparing various hair loss treatments ranked oral dutasteride 0.5 mg as the most effective medical therapy for male pattern hair loss (dutasteride 0.5 mg/day, taken orally, was more effective than either oral finasteride 1 mg/day or oral minoxidil 5 mg/day). Dutasteride outperformed finasteride and all minoxidil formulations in terms of increasing total and terminal hair density at 24 and 48 weeks.

On average, men taking dutasteride saw better density gains in less time, especially in the crown area. That said, finasteride still works well for most men, particularly if you start early.

Side-Effect Snapshot

Erectile dysfunction is the most frequently reported issue, followed by decreased ejaculatory volume and reduced libido. These effects appear in a small percentage of users and are typically dose-dependent and reversible upon discontinuation.

Sexual Dysfunction

Sexual adverse effects are the most frequently reported complications associated with finasteride use. Erectile dysfunction is the most common, followed by ejaculatory dysfunction and loss of libido.

In studies where patients were prescribed finasteride at 5 mg per day, findings indicate:

• Erectile dysfunction was reported in 3.4% to 15.8% of patients, compared to 1.7% to 6.3% in those on placebo.
• Decreased libido affected 2.36% to 10.0% of patients, versus 1.2% to 6.3% in the placebo group.
• Ejaculatory dysfunction occurred in 0.9% to 5.7% of patients, while 0.5% to 1.7% of placebo patients experienced it.

These side effects are usually mild and reversible when the medication is stopped.

Clinical Note

Finasteride 5 mg daily is primarily indicated for benign prostatic hyperplasia (BPH) and is not commonly used in dermatologic settings. It’s also important to consider that prostate conditions themselves are independent risk factors for erectile dysfunction, which may confound assessments of sexual side effects in patients taking the higher dose.

Like finasteride users, some men taking dutasteride have reported sexual dysfunction. One study of dutasteride use in men with BPH found that:

• Erectile dysfunction occurred in 7.3%,
• Decreased libido in 4.2%,
• And ejaculation disturbances in 2.2% of patients.

Crucially, head-to-head trials for hair loss have found no statistically significant difference in sexual side effect rates between finasteride and dutasteride.8

Mood and Depression

There have been reports (mostly post-marketing) of mood changes, depression, and anxiety in some men taking 5-AR inhibitors. A 2020 pharmacovigilance analysis and a 2025 review highlighted a signal for increased reports of depression and suicidal ideation in finasteride users, particularly younger men.

While causation isn’t proven, the FDA added warnings about potential mood side effects. Dutasteride, by analogy, could have similar effects, though data are more limited. Overall, the risk appears low, but patients and doctors are advised to monitor for mood symptoms.

Pregnancy & Fetal Development

Women must not use or come into contact with these drugs if pregnant. Finasteride and dutasteride can cause birth defects in a male fetus by disrupting DHT (which is crucial for male genital development).

Dutasteride carries a greater risk because its half-life is 5-6 weeks, significantly longer than finasteride’s 4-6 hours.

Strategies to Mitigate Risk

• Quarter-dosing: Some men cut pills into quarters to find the lowest effective dose.
• Alternate-day use: Especially with dutasteride, which stays in your system longer.
• Cycle on/off: The concept of periodic breaks (e.g., 1–2 weeks off every few months) is discussed anecdotally to possibly reset any side effects.
• Topical versions: Especially finasteride. Lower systemic absorption, similar local DHT reduction.

FDA vs Off-Label Status

Finasteride (Propecia) is FDA-approved for male pattern hair loss at 1 mg/day. It’s the gold standard first-line prescription for AGA.

Dutasteride (Avodart) is not FDA-approved for hair loss. The medication is FDA-approved for the treatment of BPH, but its use for hair loss is considered off-label.

What that means in practice: Physicians can legally prescribe dutasteride for androgenetic alopecia if they determine it’s medically appropriate. However, insurance may not cover the cost, and you’ll need to provide informed consent acknowledging the off-label use.

International note: Dutasteride is officially approved for hair loss in Japan, South Korea, and Taiwan. In Asia, it’s often the first-line choice.

Choosing the Right Option

Age and Family History

If you’re in your 20s or early 30s with gradual thinning, finasteride is usually enough. Especially if you have a moderate family history or your hairline is just starting to recede.

If you’re noticing fast progression or have a family history of early baldness, dutasteride might be the stronger preventive play.

Combo Therapy with Minoxidil / LLLT / PRP

Stacking treatments improves your odds. Here are common combos:

• Minoxidil: Speeds up hair growth cycles. Comes in topical or oral form.
• LLLT (low-level laser therapy): At-home laser caps that stimulate blood flow to follicles.
• PRP (platelet-rich plasma): In-office injections of growth factors taken from your own blood.

These approaches are most effective when combined with a DHT-blocking medication. For a deeper look at complementary therapies, see our guide to non-surgical hair restoration options.

Cost & Convenience

Finasteride (1 mg daily): $10–20/month (generic)

Dutasteride (0.5 mg daily): $20–40/month (generic)

Topicals: Can run $60–90/month if compounded, especially for finasteride + minoxidil mixes.

Refill Cadence

• Finasteride: Daily pill, clears fast (half-life ~6 hours)
• Dutasteride: Can be taken less frequently in some cases (half-life ~5 weeks)

That long half-life makes dutasteride forgiving if you miss a dose—and some doctors prescribe it 2–3x/week instead of daily.

FAQs Men Ask in 2025

Does dutasteride ruin future transplants?

Not at all. In fact, it can preserve existing hair around transplanted areas, improving long-term results.

Can I switch from dutasteride back to finasteride?

Yes, though you may notice some regression if finasteride isn’t sufficient to maintain the gains achieved with dutasteride. Gradual tapering can help ease the transition and allow your provider to monitor any changes in shedding or density.

Will I lose hair if I stop taking it?

Yes. DHT levels return to normal, and miniaturization resumes. You’ll likely catch up to where you’d be without treatment.

Can I combine it with oral minoxidil?

Yes. This is a popular combo. Oral minoxidil stimulates regrowth while DHT blockers protect existing follicles.

Dutasteride vs Finasteride for Hair Loss – Conclusion

If you’re serious about keeping your hair, the best next step is a conversation with a hair restoration provider. At ForHair, we specialize in personalized treatment plans, including finasteride and dutasteride, as well as advanced therapies like stem cell, exosomes, and CRP therapy.

No one-size-fits-all. But the earlier you act, the more hair you keep.

Book your free consultation online to find out which option is right for your hair type, goals, and medical profile.

BOOK NOW

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting or changing any treatment for hair loss.

References:

1. “DHT (Dihydrotestosterone): What Is DHT’s Role in Baldness?” Www.medicalnewstoday.com, www.medicalnewstoday.com/articles/68082.
2. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999 Oct;41(4):550-4. PMID: 10495374.
3. Almudimeegh A, AlMutairi H, AlTassan F, AlQuraishi Y, Nagshabandi KN. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review. Dermatol Reports. 2024 Apr 12;16(4):9909. doi: 10.4081/dr.2024.9909. PMID: 39749123; PMCID: PMC11694415.
4. Gubelin Harcha, Walter et al., A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia, Journal of the American Academy of Dermatology, Volume 70, Issue 3, 489 – 498.e3
5. Gupta AK, Bamimore MA, Williams G, Talukder M. Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. J Cosmet Dermatol. 2025 Jul;24(7):e70320. doi: 10.1111/jocd.70320. PMID: 40586152; PMCID: PMC12207719.
6. Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56-62.
7. Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 2002;60(3):434-441. doi:10.1016/s0090-4295(02)01905-2
8. Choi GS, Sim WY, Kang H, Huh CH, Lee YW, Shantakumar S, Ho YF, Oh EJ, Duh MS, Cheng WY, Bobbili P, Thompson-Leduc P, Ong G. Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study. Ann Dermatol. 2022 Oct;34(5):349-359. https://doi.org/10.5021/ad.22.027
9. Min, Dan. “Dutasteride vs. Finasteride.” Innerbody, Innerbody Research, 17 Jan. 2025, www.innerbody.com/dutasteride-vs-finasteride. Accessed 30 July 2025.